| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 789.389 | 94 |
| GSM780708 | Untreated after 4 days (C2_1) | 1130.58 | 96 |
| GSM780709 | Untreated after 4 days (C3_1) | 1002.29 | 96 |
| GSM780719 | Untreated after 4 days (C1_2) | 731.093 | 94 |
| GSM780720 | Untreated after 4 days (C2_2) | 1222.49 | 96 |
| GSM780721 | Untreated after 4 days (C3_2) | 1066.27 | 96 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 1222.49 | 96 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 827.55 | 95 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 788.532 | 94 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 979.907 | 95 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 788.779 | 94 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 830.179 | 95 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 834.931 | 95 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 992.922 | 96 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 808.254 | 95 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 729.02 | 94 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 993.436 | 96 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 843.101 | 95 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 796.087 | 94 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 774.167 | 94 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 812.261 | 95 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 895.33 | 95 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 870.215 | 95 |